Knight Rewarded for Doing Pro Bono
MONTREAL, QUEBEC--(Marketwired - Mar 28, 2017) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has assigned its secured loan issued to Pro Bono Bio PLC ("Pro Bono …